Catalyst Pharmaceuticals Partners, Inc. Balance Sheet
CPRX / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 15 fiscal years. All figures from audited SEC 10-K filings.
Catalyst Pharmaceuticals Partners, Inc. had $1.1B in total assets and $954M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 4.78 (safe zone, above 2.9 threshold)
- Strong profit margin: 33.3%
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $709.2M | $517.6M | $137.6M | $298.4M | $171.4M | $130.2M | $89.5M | $16.6M | $13.9M | $13.9M | $28.2M | $9.1M | $2.2M | $1.4M | $6.0M |
| Accounts Receivable | $126.5M | $65.5M | $53.5M | $10.4M | $6.6M | $6.0M | $10.5M | - | - | - | - | - | - | - | - |
| Inventory | $37.2M | $19.5M | $15.6M | $6.8M | $7.9M | $4.7M | $2.0M | $56.0K | - | - | - | - | - | - | - |
| Current Assets | $894.0M | $623.6M | $219.3M | $320.8M | $210.1M | $159.2M | $111.4M | $55.2M | $85.2M | $41.5M | $59.9M | $43.8M | $25.3M | $16.7M | $6.2M |
| PP&E (Net) | $1.0M | $1.4M | $1.2M | $847.0K | $959.0K | $130.0K | $210.5K | $245.4K | $191.4K | $244.2K | $191.5K | $71.4K | $40.6K | $53.7K | $12.2K |
| Total Assets | $1.1B | $851.4M | $470.1M | $375.6M | $237.8M | $192.4M | $112.4M | $60.4M | $85.4M | $41.7M | $60.1M | $43.9M | $25.4M | $16.8M | $6.2M |
| Current Liabilities | $147.2M | $120.7M | $76.1M | $57.6M | $27.1M | $22.8M | $24.1M | $9.5M | $4.3M | $2.1M | $3.4M | $5.9M | $2.1M | $1.6M | $833.8K |
| Shareholders' Equity | $954.3M | $727.6M | $387.9M | $300.4M | $206.8M | $169.6M | $87.6M | $50.8M | $39.3M | $39.3M | $55.5M | $35.2M | $21.4M | $14.6M | $3.8M |